Trial Profile
TACROLIMUS - DACLIZUMAB - MYCOPHENOLATE MOFETIL IMMUNE PROPHYLAXIS IN PEDIATRIC LIVER TRANSPLANTATION. An open, pilot, investigator-driven study in 20 recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2018
Price :
$35
*
At a glance
- Drugs Daclizumab (Primary) ; Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2018 This study has been completed in Belgium.
- 26 Jul 2011 New trial record